The deal includes two recently approved GSK products for metastatic ... The interaction with GSK goes deeper, with Novartis and GSK announcing a merger of their OTC divisions to create a new ...

The global sore throat lozenges market is projected to be valued at USD 4.4 billion in 2024 and is expected to grow at a CAGR of 5.6%, reaching an estimated value of approximately USD 7.5 billion by ...

Thailand Pharmaceutical Industry, according to Fitch Solutions, the pharmaceutical market in Southeast Asia has a market size ...

Takeda Consumer Healthcare sells OTC medicines and other health products with sales of 60 billion ... health business in recent years include Novartis, Merck KGaA, and Bristol-Myers Squibb as ...

Novartis is paying $150 million for a closer look at Schrödinger’s catalog of programs. The Big Pharma will work with Schrödinger to advance some of the computing-enabled R&D shop’s discovery programs ...

Novartis (NVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Steve Scala from ...

Watch out, Gilead and Novartis: there's a new CAR-T in town ... during its FELIX study over the peak of the COVID-19 pandemic. Currently, the product delivery team at the Nucleus is targeting an ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

The global oral solid dosage pharmaceutical formulation market is poised for remarkable expansion, with projections indicating a growth from USD 629,582.6 million in 2024 to USD 895,636.0 million by ...